Aethlon Medical (AEMD) Common Equity (2011 - 2026)

Aethlon Medical's Common Equity history runs 16 years deep, the most recent figure standing at $4.9 million for Q1 2026.

• Quarterly Common Equity fell 4.63% year-over-year to $4.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.9 million (down 4.63% YoY) and the FY2026 annual result came in at $4.9 million, down 4.63% from the prior year.
• Common Equity was $4.9 million for Q1 2026 at Aethlon Medical, down from $6.7 million in the prior quarter.
• Across five years, Common Equity topped out at $19.9 million in Q3 2022 and bottomed at $3.4 million in Q2 2025.
• A 5-year average of $9.8 million and a median of $7.6 million in 2023 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2022 — Common Equity soared 82.83% — and 2024, when it slumped 61.72%.
• Aethlon Medical's Common Equity stood at $17.3 million in 2022, then slumped by 55.95% to $7.6 million in 2023, then plunged by 43.06% to $4.3 million in 2024, then jumped by 54.89% to $6.7 million in 2025, then retreated by 27.21% to $4.9 million in 2026.
• Business Quant data shows AEMD's Common Equity at $4.9 million in Q1 2026, $6.7 million in Q4 2025, and $5.7 million in Q3 2025.